Marty McDermut Joins Luventix Advisory Board
Luventix, a leading innovator in Intelligent Disease Diagnostics, is pleased to announce that Marty McDermut has joined its Advisory Board.
Marty brings a wealth of experience in financial leadership, combining "BIG FOUR" accounting firm partner expertise with executive-level financial management in both public and private entities. His extensive background spans manufacturing, large multinational organizations, and high-growth entities, making him a valuable addition to Luventix's strategic advisory team.
With a proven track record as a strategic leader, Marty provides much more than accurate financial reporting. He excels in supporting the Board of Directors and executive leadership with transactions that drive business growth. His ability to provide a balanced perspective empowers companies to confidently pursue their short-term and long-term objectives.
"We are thrilled to welcome Marty McDermut to our Advisory Board," said George Holmes, CEO of Luventix. "His strategic financial expertise and leadership will be instrumental in guiding our growth and ensuring sound business decisions as we continue to innovate in the diagnostics industry."
About Luventix:
Luventix is a medical diagnostics company utilizing a simple, non-invasive urine test to detect and diagnose diseases through metabolomics modeling. By leveraging proprietary advanced machine learning (ML) modeling techniques, Luventix has the unique ability to analyze data and pinpoint disease-specific signatures within a Digital Twin, bridging the gap between diagnostics and therapeutics, revolutionizing clinical trial recruitment, and enabling companion diagnostics as an integral endpoint.
With a commitment to innovation, collaboration, and excellence, Luventix is redefining industry standards and making a meaningful impact on healthcare outcomes. By combining cutting-edge technology with strategic partnerships, Luventix aims to transform the landscape of personalized medicine and accelerate the delivery of life-changing solutions. For more information, please visit www.luventix.com.
Media Contact:
